Dark Forest Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Dark Forest Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,451	Closed	-$585K	–	882
2026 Q1	$585K	Sell	40,451 -99,849	-71%	-$1.43M	0.05%	522
2025 Q4	$2M	Buy	+140,300	New	+$1.38M	0.09%	386
2025 Q3	–	Sell	-311,561	Closed	-$1.79M	–	1262
2025 Q2	$1.79M	Sell	311,561 -315,276	-50%	-$2.03M	0.07%	496
2025 Q1	$5.11M	Buy	626,837 +588,689	+1,543%	+$5.45M	0.23%	71
2024 Q4	$359K	Buy	+38,148	New	+$397K	0.05%	581
2022 Q1	–	Sell	-667	Closed	-$8K	–	1441
2021 Q4	$8K	Sell	667 -4,171	-86%	-$46.5K	﹤0.01%	1004
2021 Q3	$46K	Buy	4,838 +4,604	+1,968%	+$47.1K	0.02%	590
2021 Q2	$2K	Buy	+234	New	+$2.28K	﹤0.01%	754

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dark Forest Capital Management's FOLD Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 40,451 shares — an estimated $585K sold.

Dark Forest Capital Management first reported a position in FOLD in Q2 2021 and held it in 8 quarters. The position peaked at $5.11M in Q1 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Dark Forest Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Dark Forest Capital Management sold 40,451 Amicus Therapeutics shares in Q2 2026, an estimated $585K.
Dark Forest Capital Management first reported a position in Amicus Therapeutics in Q2 2021 and held it in 8 quarters.
Dark Forest Capital Management's Amicus Therapeutics position peaked at $5.11M in Q1 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.